This module introduces the subject of pharmacogenetics and pharmacogenomics, and explains the meaning of these terms and other common terminology used about gene expression and drugs. It looks at how use of pre-emptive pharmacogenomic testing may develop in the future and considers ethical concerns related to testing.
Contributing author: Dr Martin Duerden FRCGP, medical adviser, Diploma in Therapeutics, Cardiff University and co-author of ‘Symptoms in the Pharmacy’